Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Jul 08, 2026
LyondellBasell Industries (LYB) Stock Falls -15.3% Over 30 Days as Index Removal and Analyst Downgrades Hit Hard

LyondellBasell Industries (LYB) Stock Falls -15.3% Over 30 Days as Index Removal and Analyst Downgrades Hit Hard

Key Takeaways

  • LyondellBasell shares fell approximately 15.3% over the past 30 days, dropping from $64.50 on June 5 to $54.60 on July 7, 2026, as multiple headwinds converged on the stock.
  • The decline was amplified by the company's removal from the Russell 1000 Defensive Index suite on June 27, triggering repositioning by institutional and rules-based funds.
  • Analyst price target cuts from Royal Bank of Canada, Citigroup, and others during the period added downward pressure, with RBC slashing its target from $94 to $65.
  • Broader concerns about global petrochemical demand, lingering overcapacity, and the sustainability of war-related margin benefits weighed on investor sentiment.
  • Over the quarter, the stock has declined roughly 27%, retreating sharply from its 52-week high of $83.94 reached on March 31, 2026.

Understanding LyondellBasell’s Business and Market Position

LyondellBasell Industries N.V. is one of the world's largest independent chemical companies, operating across five segments: Olefins and Polyolefins - Americas, Olefins and Polyolefins - Europe/Asia/International, Intermediates and Derivatives, Advanced Polymer Solutions, and Technology. The company produces polyethylene, polypropylene, propylene oxide, oxyfuels, and advanced polymers used in packaging, automotive, construction, electronics, and consumer goods. With a market capitalization of approximately $17 billion, LYB is a large-cap materials stock followed closely by investors for its sensitivity to global petrochemical cycles, feedstock costs, and macroeconomic demand trends. The company's cost-advantaged U.S. Gulf Coast assets and its portfolio transformation strategy—including the recent sale of four European sites—are central to its long-term investment narrative.

LYB Stock Performance: 30-Day Decline Compared to the Quarter

Over the last 30 days, LYB shares declined from $64.50 at the close on June 5, 2026, to $54.60 on July 7, 2026—a drop of approximately 15.3%. The selloff was not a single-day event but rather a persistent grind lower, with the stock recording a seven-day losing streak in late June that alone accounted for a cumulative decline of roughly 13%. The stock broke below its 50-day simple moving average in late May and has remained beneath that level throughout the period, while still trading below its 200-day moving average.

Zooming out to the quarterly view, the decline is even steeper. From its 52-week high of $83.94 on March 31, 2026, LYB has fallen approximately 35%. The stock entered the second quarter with strong momentum, buoyed by tightening petrochemical supply due to the Middle East conflict and a Q1 earnings beat. However, that momentum reversed sharply as the quarter progressed, with the stock giving back nearly all of its year-to-date gains. The three-month decline of roughly 27% stands in stark contrast to the S&P 500, which posted gains over the same period.

Factors Behind the Recent 30-Day Selloff in LYB

Several converging factors drove LYB's sharp decline over the past 30 days. The most significant catalyst was the company's removal from the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index on June 27, 2026. This reclassification forced rules-based funds and institutional portfolios benchmarked to these defensive indices to rebalance, creating sustained selling pressure. The removal reflected deteriorating metrics in LYB's financial profile, including a 2025 net loss of $745 million and a payout ratio that had turned deeply negative.

Analyst actions compounded the negative sentiment. Royal Bank of Canada lowered its price target from $94 to $65 on July 1, while Citigroup reduced its target from $80 to $67 in late June. Goldman Sachs maintained a sell rating with a $75 target. Weiss Ratings downgraded LYB from "hold" to "sell" on June 24. These revisions highlighted concerns about the durability of petrochemical margin improvements and the company's ability to sustain its reduced dividend.

Insider selling activity also weighed on confidence, with approximately $0.7 million in insider sales recorded over the prior three months and no corresponding buying activity. Additionally, broader macroeconomic uncertainty—including tariff risks, fluctuating crude oil prices, and questions about the pace of global capacity rationalization—kept buyers on the sidelines. While the Middle East conflict has steepened the global petrochemical cost curve in LYB's favor, investors increasingly questioned whether those benefits would persist long enough to offset structural headwinds.

Quarterly Performance Drivers and Market Reassessment

The quarterly decline of roughly 27% reflects a broader reassessment of LYB's risk-reward profile. The stock had rallied sharply earlier in 2026, gaining over 50% year-to-date by late March, as investors priced in the earnings upside from Middle East supply disruptions. The company's Q1 2026 results, reported on May 1, showed adjusted EPS of $0.49—beating estimates by $0.18—and EBITDA excluding identified items of $615 million, nearly 50% above the prior quarter. Management guided for significant sequential improvement in Q2, citing tighter supply dynamics and favorable pricing trends.

Despite the strong operational performance, the market began to focus on risks that the earnings beat had masked. Revenue of $7.2 billion missed analyst estimates of $7.53 billion, declining 6.3% year-over-year. The 50% dividend cut announced earlier in the year—from $1.37 to $0.69 per share—continued to weigh on income-oriented investors. The company's 2025 net loss of $745 million and a payout ratio of -237% underscored the financial strain that preceded the cut. As the quarter progressed, concerns about global overcapacity, particularly in polypropylene, and the potential for demand destruction if polymer prices rose too far, eroded confidence in the sustainability of the margin recovery. The Russell index removal in late June served as a culminating event that crystallized these concerns into accelerated selling.

One Tool That Has Helped Me Navigate Similar Situations

In volatile market environments like the one currently affecting LYB, I often look to data-driven resources for additional perspective. Tickeron’s AI Trading Bots provide a selection of AI-powered strategies that analyze thousands of tickers using technical analysis, pattern recognition, and momentum signals. These tools adapt to changing conditions and highlight approaches that have shown effectiveness in real time, offering a useful complement to traditional fundamental research when assessing how stocks like LYB might behave going forward.

What to Watch for LYB Going Forward

Looking ahead, several factors will determine whether LYB can stabilize and recover. The company's second-quarter 2026 earnings, scheduled for release on July 31, will be a critical checkpoint. Management guided for significant sequential improvement, and investors will scrutinize whether polyethylene and polypropylene pricing gains translated into margin expansion, and whether the Bayport PO/TBA facility restart progressed as planned. Any deviation from guidance could trigger further repositioning.

Geopolitical developments in the Middle East remain a wildcard. CEO Peter Vanacker stated the supply disruption would persist for "multiple quarters, definitely not months," but any progress toward de-escalation could rapidly unwind the cost-curve advantages that have supported LYB's North American and European assets. On the structural side, progress on China's anti-involution policies and the pace of global ethylene capacity rationalizations will shape the medium-term supply-demand balance. The company's Cash Improvement Plan, targeting $500 million in incremental cash flow for 2026, and the integration of the European asset sales will also be closely monitored as indicators of management's ability to strengthen the balance sheet and defend the reduced dividend. Finally, macroeconomic signals—including interest rate trajectories, consumer confidence, and durable goods demand—will influence the demand outlook for LYB's core polymer products.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LYB

LYB's RSI Oscillator climbs out of oversold territory

The RSI Indicator for LYB moved out of oversold territory on October 01, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In 15 of the 24 cases the stock moved higher. This puts the odds of a move higher at 62%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 60 cases where LYB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.

Following a +2.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where LYB advanced for three days, in 183 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.

LYB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LYB as a result. In 59 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 58%.

The Moving Average Convergence Divergence Histogram (MACD) for LYB turned negative on September 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 24 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.

LYB moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LYB crossed bearishly below the 50-day moving average on September 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LYB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

The Aroon Indicator for LYB entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.764) is normal, around the industry mean (6.363). P/E Ratio (98.766) is within average values for comparable stocks, (209.940). Projected Growth (PEG Ratio) (1.526) is also within normal values, averaging (1.548). LYB's Dividend Yield (0.059) is considerably higher than the industry average of (0.013). P/S Ratio (0.670) is also within normal values, averaging (48.960).

The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. LYB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LYB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.08B. The market cap for tickers in the group ranges from 50 to 217.6B. LIN holds the highest valuation in this group at 217.6B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was 1%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -0%. STDN experienced the highest price growth at 20%, while CNEY experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was -10%. For the same stocks of the Industry, the average monthly volume growth was 15% and the average quarterly volume growth was -31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 55
Price Growth Rating: 56
SMR Rating: 78
Profit Risk Rating: 82
Seasonality Score: 30 (-100 ... +100)
View a ticker or compare two or three
LYB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of petrochemicals

Industry ChemicalsSpecialty

Industry
Chemicals Specialty
Address
One Vine Street
Phone
+44 2072202600
Employees
18970
Web
https://www.lyondellbasell.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.